Filing Details
- Accession Number:
- 0001367644-20-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-08 20:19:35
- Reporting Period:
- 2020-04-06
- Accepted Time:
- 2020-04-08 20:19:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1778426 | Sean Kirk | 400 Professional Drive, Suite 400 Gaithersburg MD 20879 | Evp, Manufacturing & Tech Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-04-06 | 5,666 | $60.00 | 12,571 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-04-06 | 3,135 | $30.86 | 15,706 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-04-06 | 3,135 | $60.00 | 12,571 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-04-06 | 7,293 | $30.63 | 19,864 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-04-06 | 7,293 | $60.00 | 12,571 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Employee Stock Options (Right To Buy) | Employee Stock Options (Right to Buy) | Disposition | 2020-04-06 | 3,135 | $60.00 | 3,135 | $30.86 |
Employee Stock Options (Right To Buy) | Employee Stock Options (Right to Buy) | Disposition | 2020-04-06 | 7,293 | $60.00 | 7,293 | $30.63 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
38,805 | 2021-02-28 | No | 4 | S | Direct | |
31,512 | 2022-02-27 | No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk.
- Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated.
- The options vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company.